AzTrials
AzTrials

AnesthesiaNCT05601622

RPVI for Fluid Responsiveness in Children

A study testing Fluid loading, Transthoracic echocardiography and PVI, RPVI in people with Anesthesia and Fluid Responsiveness, run by Seoul National University Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to validate Rainbow pleth variability index for prediction of fluid responsiveness in children. Read more about this study

Who is it for?
Ages Up to 6 years
Conditions the study is for
Anesthesia, Fluid Responsiveness
What is being tested?
Fluid loading, Transthoracic echocardiography and PVI, RPVI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
No sites listed yet
Study dates
15 Nov 2022to 20 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children undergoing neurosurgery under general anesthesia

Who cannot join

  • Presence of any cardiovascular disease
  • Presence of any pulmonary disease
  • Decline of enrollment from any of the patient's parents

Trial locations and contacts

No sites are listed yet.

Sang-Hwan Ji, M.D., Ph.D. contact

+82220723661

taepoongshin@gmail.com

About this study

Official title: Assessment of Predictive Power for Fluid Responsiveness of Rainbow Pleth Variability Index in Children

The purpose of this study is to validate Rainbow pleth variability index for prediction of fluid responsiveness in children.

Read the detailed description

Children undergoing surgery under general anesthesia will be enrolled. After anesthetic induction, they will be assessed via transthoracic echocardiography for measurement of the patient's stroke volume index (SVI). Also, pleth variability index and Rainbow pleth variability index will be measured under mechanical ventilation with tidal volume of 6, 8, 10 ml/kg.

To exert fluid loading, 10ml/kg of crystalloid solution will be administered intravenously over 10 minutes. After fluid loading, the SVI will be measured again and fluid responsiveness will be determined according to increment ratio of the SVI.

According to the determined fluid responsiveness, predictive power of pleth variability index and Rainbow pleth variability index for fluid responsiveness will be assessed by building a receiver-operating characteristics curve.

Being tested
Fluid loading, Transthoracic echocardiography, PVI, RPVI, Tidal volume change
Keywords
Fluid responsiveness, pleth variability index

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluid loadingProcedure or surgery

    Intravenous administration of 10ml/kg of crystalloids over 10 minutes

  • Transthoracic echocardiographyDiagnostic test

    Transthoracic echocardiographic measurement of stroke volume index

  • PVI, RPVIDiagnostic test

    Continuous measurement of pleth variability index and Rainbow pleth variability index

  • Tidal volume changeProcedure or surgery

    Changing tidal volume for mechanical ventilation as 6, 8, 10 ml/kg

Study groups in NCT05601622
Study groupRoleWhat they receive
Study groupExperimentalFluid loading, Stroke volume index measurement via transthoracic echocardiography, measurement of pleth variability index and Rainbow pleth variability index, change of tidal volume under mechanical ventilation
Receives: Procedure: Fluid loading; Diagnostic Test: Transthoracic echocardiography; Diagnostic Test: PVI, RPVI; Procedure: Tidal volume change

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AUC of ROC curve

    Area under the curve of the receiver-operating characteristics curve of pleth variability index and Rainbow pleth variability index for prediction of fluid responsiveness

    Measured: From start of anesthesia to end of anesthesia, Less than 24 hours

Secondary outcomes (3)
  1. Appearance of abnormal heart rhythm

    Electrocardiogram during the study for monitoring whether tachycardia, bradycardia, or arrhythmia appears. Heart rate will be compared between patients who were fluid responsive and who were not responsive.

    Measured: From start of anesthesia to end of study, Less than 24 hours

  2. IBP

    Invasive blood pressure during the study, including systolic, diastolic, mean blood pressure for monitoring whether hypertension or hypotension appears. Mean blood pressure will be compared between patients who were fluid responsive and who were not responsive.

    Measured: From start of anesthesia to end of study, Less than 24 hours

  3. SpO2

    Pulse oximetry during the study for monitoring whether hypoxia appears.

    Measured: From start of anesthesia to end of study, Less than 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2022
  2. Study start15 Nov 2022 (estimated)
  3. Primary completion20 Oct 2024 (estimated)
  4. Study completion20 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05601622
Sponsor's protocol ID
2209-123-1363
Status last verified
Nov 2022
First submitted
20 Oct 2022
Last updated
16 Nov 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gan H, Cannesson M, Chandler JR, Ansermino JM. Predicting fluid responsiveness in children: a systematic review. Anesth Analg. 2013 Dec;117(6):1380-92. doi: 10.1213/ANE.0b013e3182a9557e.

    PubMed 24257389
  • Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, Orr RA. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003 Oct;112(4):793-9. doi: 10.1542/peds.112.4.793.

    PubMed 14523168
  • Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77. doi: 10.1056/NEJMoa010307.

    PubMed 11794169

Questions about this trial

What is this clinical trial studying?

A study testing Fluid loading, Transthoracic echocardiography and PVI, RPVI in people with Anesthesia and Fluid Responsiveness, run by Seoul National University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sang-Hwan Ji, M.D., Ph.D. (+82220723661, taepoongshin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AUC of ROC curve (time frame: From start of anesthesia to end of anesthesia, Less than 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05601622, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
RPVI for Fluid Responsiveness in Children | AzTrials